Novartis shipping flu vax; Sun recalls cancer drug; Ex-Pfizer exec Schulman named to Alnylam board;

@FiercePharma: Top on FiercePharmaMarketing: Facing threats from Purdue, Teva and Pfizer, Zogenix puts Zohydro follow-up into high gear. Story | Follow @FiercePharma

@TracyStaton: RT @JohnCFierce: Genentech pays $725M upfront for game-changing breast cancer drug - Seragon, spun out after Aragon deal. Article | Follow @TracyStaton

@EricPFierce: Laclede says it will alter labeling for vaginal gel products after FDA seeks injunction. More | Follow @EricPFierce

@CarlyHFierce: UPDATED: Agenus' genital herpes vax cuts viral load 75% in PhII. News | Follow @CarlyHFierce

> Novartis ($NVS) has begun shipping its Flucelvax and Fluvirin seasonal influenza vaccines to U.S. customers and says it will send a minimum of 30 million doses for the 2014-2015 season. Release

> The U.K., along with Spain and Portugal, were left out off the World Health Organization's list of 33 countries with a chance to eliminate TB altogether because their rates run too high to be included, 150 in 1 million in the U.K.'s case compared to 1 in 1 million in the U.S. Story

> Chinese drugmaker Luye Pharma Group is preparing to raise $764 million from a Hong Kong initial public offering sources tell Bloomberg. Story

> Indian drugmaker Sun Pharmaceutical's Caraco subsidiary has recalled 200 vials of the cancer drug Gemcitabine over concerns about sterility. Announcement

> Amy Schulman, the former Pfizer ($PFE) corporate counsel who suddenly departed a top spot at the drugmaker in December, has been named to the board of directors of biotech Alnylam Pharmaceuticals ($ALNY). Release

> A California judge has dismissed claims by 219 plaintiffs against GlaxoSmithKline ($GSK) who said they had heart problems tied to diabetes drug Avandia. Report

Medical Device News

@FierceMedDev: Who were the highest-paid med tech CEOs in 2013? Read up in our new report. Read | Follow @FierceMedDev

@StacyALawrence: Researchers use wearable iPad to assess multiple sclerosis symptoms. Item | Follow @StacyALawrence

@VarunSaxena2: Exec talks on Covidien's fit with Medtronic. More | Follow @VarunSaxena2

@MichaelGFierce: A tiny, "walking" robot powered by a muscle cell? It could help deliver drugs one day. More | Follow @MichaelGFierce

@EmilyWFierce: Encision nabs FDA clearance for next-generation wound-care technology. More | Follow @EmilyWFierce

> FDA clears first vital sign sensor for chairs. Story

> FDA clears device to prevent stray laproscopic surgical burns. More

> GlassesOff visual improvement app scores $15M; J&J settles hip implant suit. Article

Biotech News

@FierceBiotech: Chutes&Ladders: Former Pfizer's general counsel Schulman joins Alnylam's board. Story | Follow @FierceBiotech

@JohnCFierce: Alzheimer's R&D suffers as trial failure rate hits an "astounding" 99.6%. More | Follow @JohnCFierce

@DamianFierce: I have no idea what the next move for the Aragon/Seragon team is, but do note that Paragon Pharma is already taken. | Follow @DamianFierce

@EmilyMFierce: Acid-bath stem cell papers are finally retracted. Story via New Scientist | Follow @EmilyMFierce

> NIH readies $248M program for electroceuticals. Item

> FDA gives an early OK to lymphoma drug Beleodaq. Story

> Bind shares slide after Amgen walks out of $180M collaboration deal. More

Vaccines News

> Novartis starts shipping Flucelvax ahead of upcoming flu season. More

> Agenus brain cancer vaccine boosts survival in PhII trial. News

> Sanofi, CureVac extend vax partnership with new $205M-plus mRNA pact. Piece

> PaxVax' oral cholera vaccine succeeds in PhIII challenges. Item

> Prevnar use in seniors is cost-effective now, CDC says. But will it last? Story

> Agenus' genital herpes vax cuts viral load 75% in PhII. More

Pharma Manufacturing News

> AMRI finishes second manufacturing buy in 3 months. Read

> Pfizer recalling 221,000 bottles of Pristiq as tablet mix-up again trips it up. Piece

> Bristol-Myers recalls 6 lots of injected Coumadin. News

> FDA lays out some cGMP guidance for drug compounders. Item

> Pfizer gets access to more production capacity in Saudi Arabia with Tabuk deal. More

> FDA sues to halt production of 'unapproved' vaginal gel products. Article

And Finally... A new report says that 40% of cases in the U.K. of the highly lethal pancreatic cancer are preventable if people maintained a healthy body weight and didn't smoke. Story

Suggested Articles

After Purdue’s record opioid settlement, more deals could be on the way. But that doesn’t mean all defendants are prepared to go quietly.

Now in their third quarter on the market, Gilead's own Epclusa and Harvoni generics have together grabbed more than 20% of the U.S. hep C market.

Purdue is seeking bankruptcy after inking a $10 billion-plus opioid settlement with thousands of cities and counties, plus two dozen states.